Exchange: NASDAQ·Updated 07:30 PM EDT
LRMR logo

LRMR Larimar Therapeutics Inc

$3.82
$0.19
(4.74%)
Today
Closed $3.82
$0.07
(1.83%)
After Hours
Reported EarningsAug 4
Mkt Cap$416.57M
Vol1.07M

About LRMR

Larimar Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing treatments for patients suffering from complex rare diseases using a novel cell penetrating peptide technology platform. It also engages in the research, development, and commercialization of novel therapeutics for mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
37

Bearish Sentiment

How do you feel about LRMR?

Advertisement|Remove ads.